Medtech market stabilizing after headwinds, SVB says

The 2023 health technology market is stabilizing after a down year in 2022, as health technology stock trading and merger activity is on the rise in the first two quarters of the year.

So far, venture capital has poured $8.2 billion into the health technology sector, according to an Oct. 4 news release from Silicon Valley Bank. Additionally, the report found that public trading in health technology was up 6 percent in the first quarter and 25 percent in the second quarter.

"Following a steep drop in 2022, venture fundraising has rebounded and there is significant dry powder for right-sized investment into the healthtech sector. We expect to see more stabilization as the investment environment resets valuations to match growth and profitability targets," Julie Ebert, SVB managing director for healthtech, said in the news release.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars